Pharmaceutical

  • INR 40,000
  • USD 700
Subscribe now

The Indian Pharmaceutical Industry (IPI) is globally the 3rd largest in terms of volume and 13th largest in terms of value. The industry is expected to growth at a robust CAGR during FY2012-17 given the huge export potential coupled with steady growth in the domestic formulation market. Growth in the domestic pharma market will be driven by increase in the penetration of medical facilities, rising prevalence of chronic diseases and rising per capita income. The growth in the US market will be led by increasing generic penetration and healthy ANDA pipeline of Indian pharma players. In the long term, growth in the exports market will be sustained by emerging markets such as Russia, Brazil, and South Africa etc. along with the enhanced focus on the niche and complex product segments. The report on 'Indian Pharmaceutical Industry' gives valuable insight on basics of the industry, domestic demand and growth drivers, exports and imports statistics, regulatory landscape and a performance analysis of key players. The report also provides CARE Research's Outlook on the domestic and exports market for the next 5 years.

Download Brochure

Updates

    • Monthly Update December 2014

      Net sales grow 16%, PAT margins expand to 18.8%; pharma industry faces questions in Canada and EU....

    • Monthly Update November 2014

      US Congress to investigate rising drug prices....

    • Monthly Update October 2014

      Procedure of granting licenses under CDSCO's review....

    • Monthly Update September 2014

      NPPA scraps powers to cap prices of non-essential drugs....

    • Monthly Update August 14

      Net sales grow 18.9%, PAT margins at 16.2%; USFDA/CDSCO to enhance inspection capabilities....

    • Monthly Update July14

      Govt/regulatory policy on trade/pricing key to industry performance....

    • Monthly Update June-14

      Net sales grow 18.4%, PAT margins expand to 18.3%; 'Bulk Drugs Policy' likely soon....

    • Monthly Update May-14

      NPPA to planning to regulate prices of drug used in the treatment of HIV, Cancer, Malaria and TB....

    • Monthly Update April-14

      Sun Pharmac acquires Ranbaxy Laboratories for $ 4 billion to form India's largest pharmaceutical company....

    • Monthly Update Feb-14

      USFDA to conduct workshops in order to sensitise domestic companies about US regulatory requirements....

    • Monthly Update Jan-14

      Ranbaxy suffers a big blow, faces a third ban from USFDA....

    • Monthly Update Dec-13

      Indian companies embroiled in patent wars and USFDA warnings....

    • Monthly Update Nov-13

      Union Cabinet considering enforcing restriction on FDI in the sector....

    • Monthly Update Oct-13

      US FDA starts conducting surprise inspections of Indian companies to curb counterfeit drug manufacturing....

    • Monthly Update Sep-13

      Indian companies continue to be under the US FDA scanner....

    • Monthly Update Aug-13

      Sales growth healthy, but sharp rise in extraordinary expenses pull down the PAT margins in 1QFY14....

    • Monthly Update Jul-13

      Indian companies continue to be under the US FDA scanner; Uncertainty persists over implementation of DPCO....

    • Monthly Update Jun-13

      DPCO implementation begins....

    • Monthly Update May-13

      Sales growth healthy, but operating margins fall in 4QFY13....

    • Monthly Update Apr-13

      M&A prospects brighten; exports growth intact....

    • Monthly Update Feb-13

      Increasing exports opportunities....

    • Monthly Update Jan-13

      Shift towards chronic, key to value growth....

    • Monthly Update Dec-12

      Shift towards chronic, key to value growth....

Impact Analysis

  • Patent expiries globally, increase in chronic diseases domestically key to growth

    The Indian Pharmaceutical Industry (IPI) is globally the 3rd largest in terms of volume and 13th largest in terms of value......

    + Know More

Presentations

Please subscribe to view this report

Already Registered? Login Now

 

Pharmaceutical

Subscribe Now
 

Healthcare Coverage

Related Reports

Get Alerts

To receive CARE Research publications and alerts.

Register Now >>